Kenneth Boyer to Leucovorin
This is a "connection" page, showing publications Kenneth Boyer has written about Leucovorin.
Connection Strength
0.086
-
Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy. Arch Ophthalmol. 2008 Aug; 126(8):1152-6.
Score: 0.020
-
Cataracts in congenital toxoplasmosis. J AAPOS. 2007 Dec; 11(6):551-4.
Score: 0.019
-
Longitudinal study of new eye lesions in treated congenital toxoplasmosis. Ophthalmology. 2008 Mar; 115(3):553-559.e8.
Score: 0.019
-
Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis. Radiology. 1996 May; 199(2):433-40.
Score: 0.009
-
Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis. 1994 Jan; 18(1):38-72.
Score: 0.007
-
Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Toxoplasmosis Study Group. Antimicrob Agents Chemother. 1992 May; 36(5):1040-8.
Score: 0.006
-
Phenotypes and functions of lymphocytes in congenital toxoplasmosis. J Lab Clin Med. 1990 Nov; 116(5):623-35.
Score: 0.006